India bronchitis treatment market is projected to witness considerable growth during the forecast period. It is due to increasing awareness of the people towards health, increasing smoking habit and rising pollution across the country. Respiratory or lung diseases are highly prevalent in the country. About 15-20 million people have asthma in the country. In terms of smoking, around 120 million people smoke in India, estimating to 10% of the world’s tobacco smokers, as per the Economics of Tobacco and Tobacco Taxation in India.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/india-bronchitis-treatment-market

Therefore, the demand for bronchitis treatment is continuously rising in the country. Moreover, the rising industrialization in India, backed by the cohesive government policies, such as ‘Make in India’ initiative will further rise the pollution level in the country. As per new survey of WHO in 2018, 14 out of 20 topmost polluted cities are in India, with Kanpur, Faridabad and Varanasi being the most polluted cities. Due to this, the people would face significant respiratory diseases in the near future and hence the need for bronchitis treatment will rise during the forecast period.

A Full Report of India Medical Device Technology Market is Available at: https://www.omrglobal.com/industry-reports/india-bronchitis-treatment-market

The bronchitis treatment market is classified on the basis of type of treatment, which includes drugs and oxygen therapy. The drugs segment is further segregated into antibiotics, anti-inflammatory drugs, bronchodilators, and others. Among these types of treatments, the drugs find its significant application in the bronchitis treatment across the globe. In addition, the bronchodilator is estimated to project a considerable CAGR during the forecast period. Bronchodilators are the first-line medication used to treatment of bronchitis, to clear the airway obstruction, which is considered as first-step in chronic bronchitis to ease breathing problems.

India Medical Device Technology Market Segmentation
India Bronchitis Treatment Market by Type
• Drugs
o Antibiotics
o Anti-inflammatory drugs
o Bronchodilators
o Others (Mucolytics)
• Oxygen Therapy

India Medical Device Technology Market – Segment by Region
North America
• United States
• Canada

Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East and Africa

Company Profiles
• Abbott Laboratories
• Aurobindo Pharma Ltd.
• Bayer AG
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• Dr Reddy's Laboratories Ltd.
• GlaxoSmithKline PLC
• Lupin Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/india-bronchitis-treatment-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404